Occam Places John Reynders as Chief Data Sciences Officer of Neumora
Neumora Therapeutics, an Arch Venture Partners' investment leveraging ML to develop CNS drugs, emerged from stealth mode in 2021 with $500M in financing.
In 2020, Occam placed John Reynders, PhD, as the company's first Chief Data Sciences Officer. Prior to Neumora, John served as Vice President, data sciences, genomics and bioinformatics at Alexion, where he led the design, building and deployment of data sciences solutions spanning R&D, commercial, strategy and business development. Prior to joining Alexion, John served as the founding Chief Information Officer of Moderna Therapeutics.
Related Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.